National Academies Press: OpenBook
« Previous: References
Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×

Appendix A
Agenda

8:00–8:10

Objectives of the Workshop

 

Gail Cassell, Eli Lilly and Company

 

Workshop Chair

8:10–9:40

Panel I: SETTING THE STAGE

10-minute presentations followed by a 30-minute panel discussion

 

Moderator: Kenneth Castro, Centers for Disease Control and Prevention

 

Paul Nunn, World Health Organization

Global Incidence of MDR TB

 

Yanis Ben Amor, Earth Institute

Underreported Threat of MDR TB in Africa

 

Gerald Friedland, Tugela Ferry Care and Research Collaboration

HIV/MDR-XDR TB: Implications

Megan Murray, Brigham and Women’s Hospital

Number of MDR TB and XDR TB Patients Receiving Treatment Today: Successes/Failures/Consequences

 

Qian Gao, Shanghai Medical College

Transmission of MDR TB

Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×

 

Neel Gandhi, Tugela Ferry Care and Research Collaboration

Transmission of XDR TB

9:40–9:50

Break

9:50–11:30

Panel II: HOW DID WE GET TO WHERE WE ARE TODAY: DIFFERENT PERSPECTIVES

10-minute presentations followed by a 40-minute panel discussion

 

Moderator: Richard Chaisson, Johns Hopkins University

 

Edward Nardell, Brigham and Women’s Hospital

Lack of Infection Control

 

John Ridderhof, Centers for Disease Control and Prevention

Laboratory Capacity: A Global Analysis

 

Anne Goldfeld, Harvard School of Public Health

Drug and Health Care Delivery: Cambodian and Ethiopian Perspectives

 

Wieslaw Jakubowiak, WHO Country Office Russian Federation

Fighting Drug Resistance in Russia: Challenges and Achievements

 

Paul Zintl, Partners In Health

Drug Supply: The Stop TB Partnership Perspective

 

Ruth Levine, Center for Global Development

Critical Role of Accurate Demand Forecasting: Lessons Learned from Malaria

11:30–12:30

Lunch

12:30–1:20

Keynote Address: The Research Path to Tuberculosis Control: An NIH Perspective

 

Anthony Fauci, National Institute of Allergy and Infectious Diseases

1:20–3:00

Panel III: ESSENTIAL BUILDING BLOCKS

10-minute presentations followed by a 20-minute panel discussion

 

Moderator: Leonard Sacks, Food and Drug Administration

Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×

 

Dale Nordenberg and Hamish Fraser, Brigham and Women’s Hospital

Knowledge Management (IT): What Do We Need and What Do We Have?

 

David Persing, Cepheid, and Charles Daitch, Akonni Biosystems

Point-of-Care Diagnostics: How Close Are We?

 

Ann Ginsberg, TB Alliance

TB Drug Development: Realities of the Pipeline

 

Raymond Woosley, The Critical Path Institute

Critical Path for Parallel Development of TB Point-of-Care Diagnostic and Drug Development

 

Jeff Moe, Duke University

What Are the Odds? Who Will Pay? What Are the Incentives?

3:00–3:15

Break

3:15–4:15

Panel III: A BLUEPRINT FOR ACTION

 

Moderator: Peter Cegielski, Centers for Disease Control and Prevention

 

Salmaan Keshavjee, Partners In Health

The Plan: From Powder to Patient

 

Discussants:

 

Michael Kimerling, Bill and Melinda Gates Foundation

Carol Nacy, Sequella, Inc.

Iain Richardson, Eli Lilly and Company

Caroline Ryan, U.S. Department of State

Sarita Shah, Tugela Ferry Care and Research Collaboration

Alexander Sloutsky, University of Massachusetts

Martie Van der Walt, Medical Research Council South Africa

Charles Wells, Otsuka

4:15–5:30

Panel V: THE NEED FOR URGENCY

15-minute presentations followed by 45-minutes of discussion

 

Moderator: Jim Yong Kim, Partners In Health

Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×

 

Mark Harrington, Treatment Action Group

Lessons from HIV

 

Paul Farmer, Partners In Health

Lessons from MDR TB

5:30

SYNTHESIS AND NEXT STEPS

 

Gail Cassell, Eli Lilly and Company

Workshop Chair

Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×
Page 113
Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×
Page 114
Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×
Page 115
Suggested Citation:"Appendix A: Agenda." Institute of Medicine. 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12570.
×
Page 116
Next: Appendix B: Participant Biographies »
Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary Get This Book
×
Buy Paperback | $54.00 Buy Ebook | $43.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Drug Discovery, Development, and Translation hosted a workshop on November 5, 2008, to address the mounting concern of drug-resistant TB. The session brought together a wide range of international experts to discuss what is known and not known about this growing threat, and to explore possible solutions.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!